MintNeuro

MintNeuro is a neurotechnology company focused on developing advanced semiconductor-based neural implants for treating neurological disorders. The company aims to create scalable and less invasive solutions that integrate semiconductor technology with neural interface expertise. Their proprietary chipset architecture includes neural sensors, stimulators, and signal processors that work together to read and modulate neural activity, allowing for real-time personalization of therapies. MintNeuro's medical-grade neural implants target a variety of neurological conditions, such as epilepsy, movement disorders, cognitive impairments, Parkinson’s disease, dementia, depression, and mixed urinary incontinence. The devices are designed to be ultra-low-power, highly integrated, and miniaturized, enabling wireless functionality and minimally invasive implantation. The company has established partnerships with leading academic and medical institutions and is involved in projects aimed at developing innovative monitoring devices and neuromodulation therapies. Through initiatives like the EXPLORE program, MintNeuro seeks to broaden access to its technology and accelerate innovation in the field of neurological care.

• Employees 18
• Founded 2022